首页|Early systemic anticoagulation reduces hospital readmission in acute necrotizing pancreatitis patients:A retrospective cohort study

Early systemic anticoagulation reduces hospital readmission in acute necrotizing pancreatitis patients:A retrospective cohort study

扫码查看
Background:Early systemic anticoagulation(SAC)is a common practice in acute necrotizing pancreatitis(ANP),and its impact on in-hospital clinical outcomes had been assessed.However,whether it affects long-term outcomes is unknown.This study aimed to evaluate the effect of SAC on 90-day readmission and other long-term outcomes in ANP patients.Methods:During January 2013 and December 2018,ANP patients admitted within 7 days from the on-set of abdominal pain were screened.The primary outcome was 90-day readmission after discharge.Cox proportional-hazards regression model and mediation analysis were used to define the relationship be-tween early SAC and 90-day readmission.Results:A total of 241 ANP patients were enrolled,of whom 143 received early SAC during their hospi-talization and 98 did not.Patients who received early SAC experienced a lower incidence of splanchnic venous thrombosis(SVT)[risk ratio(RR)=0.40,95%CI:0.26-0.60,P<0.01]and lower 90-day read-mission with an RR of 0.61(95%CI:0.41-0.91,P=0.02)than those who did not.For the quality of life,patients who received early SAC had a significantly higher score in the subscale of vitality(P=0.03)while the other subscales were all comparable between the two groups.Multivariable Cox regression model showed that early SAC was an independent protective factor for 90-day readmission after adjust-ing for potential confounders with a hazard ratio of 0.57(95%Cl:0.34-0.96,P=0.04).Mediation analysis showed that SVT mediated 37.0%of the early SAC-90-day readmission causality.Conclusions:The application of early SAC may reduce the risk of 90-day readmission in the survivors of ANP patients,and reduced SVT incidence might be the primary contributor.

AnticoagulationSplanchnic venous thrombosisAcute necrotizing pancreatitisReadmissionLong-term outcomes

Wen-Jian Mao、Jing Zhou、Guo-Fu Zhang、Fa-Xi Chen、Jing-Zhu Zhang、Bai-Qiang Li、Lu Ke、Wei-Qin Li

展开 >

Department of Critical Care Medicine,Jinling Hospital,Nanjing Medical University,Nanjing 210002,China

Department of Critical Care Medicine,Jinling Hospital,Medical School of Nanjing University,Nanjing 210002,China

National Institute of Healthcare Data Science,Nanjing University,Nanjing 210010,China

National Natural Science Foundation of ChinaNational Natural Science Foundation of China

8207066581900592

2024

国际肝胆胰疾病杂志(英文版)
浙江省医学学术交流管理中心,浙江大学医学院附属第一医院,浙江大学出版社有限责任公司

国际肝胆胰疾病杂志(英文版)

影响因子:0.668
ISSN:1499-3872
年,卷(期):2024.23(1)
  • 35